SCHEMBL29089926

SCHEMBL29089926

CC#CCOC(=O)C(O)(c1ccc(N(CC)CC)cc1)C1CCCCC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 4/20 0.62
CHRM1 P11229 4/20 0.62
KCNH2 Q12809 3/20 0.62
CYP2C19 P33261 2/20 0.62
SLC6A3 Q01959 2/20 0.62
CYP3A4 P08684 2/20 0.62
CHRM4 P08173 2/20 0.62
CHRM3 P20309 2/20 0.62
CYP1A2 P05177 1/20 0.62
CYP2D6 P10635 1/20 0.62
CYP2C9 P11712 1/20 0.62
PKM P14618 1/20 0.62
NFKB1 P19838 1/20 0.62
THPO P40225 1/20 0.62
ABCB11 O95342 1/20 0.62
ESR1 P03372 1/20 0.62
CHRM5 P08912 1/20 0.62
ADRA2A P08913 1/20 0.62
ADORA3 P0DMS8 1/20 0.62
TBXA2R P21731 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7914133 0.84 CHRM2 (0.71) CHRM2CHRM1KCNH2CYP2C19SLC6A3
SCHEMBL14009870 0.79 CHRM2 (0.78) CHRM2CHRM1KCNH2CYP2C19SLC6A3
SCHEMBL13241387 0.76 CHRM2 (0.78) CHRM2CHRM1KCNH2CYP2C19SLC6A3
Oxybutynin SCHEMBL1560964 0.76 CHRM2 (1.00) CHRM2CHRM1KCNH2CYP2C19SLC6A3
Esoxybutynin SCHEMBL290373 0.76 CHRM2 (1.00) CHRM2CHRM1KCNH2CYP2C19SLC6A3
Aroxybutynin SCHEMBL25880 0.76 CHRM2 (1.00) CHRM2CHRM1KCNH2CYP2C19SLC6A3
Oxybutynin SCHEMBL2992 0.76 CHRM2 (1.00) CHRM2CHRM1KCNH2CYP2C19SLC6A3
SCHEMBL13241377 0.76 CHRM2 (0.77) CHRM2CHRM1KCNH2CYP2C19SLC6A3
SCHEMBL7915717 0.76 KCNH2 (0.83) CHRM2CHRM1KCNH2CYP2C19SLC6A3
SCHEMBL7915749 0.76 KCNH2 (0.83) CHRM2CHRM1KCNH2CYP2C19SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117956959-A Methods and compositions for treating sleep apnea 爱普宁公司(特拉华) 2024-04-30 CN disclosed
CN-117177741-A Combination of norepinephrine reuptake inhibitors and cannabinoids for the treatment of sleep apnea 爱普宁公司(特拉华) 2023-12-05 CN disclosed
CN-116916909-A Combination of reboxetine and a Muscarinic Receptor Antagonist (MRA) for the treatment of sleep apnea 爱普宁公司(特拉华) 2023-10-20 CN disclosed